Tear concentrations of levofloxacin following topical administration of a single dose of 0.5% levofloxacin ophthalmic solution in healthy volunteers
Raizman, Michael B., Rubin, Jay M., Graves, Adrienne L., Rinehart, Michael
Published in Clinical therapeutics (01.09.2002)
Published in Clinical therapeutics (01.09.2002)
Get full text
Journal Article
Perception and quality of life associated with the use of olopatadine 0.2% (Pataday) in patients with active allergic conjunctivitis
Scoper, Stephen V, Berdy, Gregg J, Lichtenstein, Steven J, Rubin, Jay M, Bloomenstein, Marc, Prouty, Robert E, Vogelson, Cullen T, Edwards, Michael R, Waycaster, Curtis, Pasquine, Terri, Gross, Robert D, Robertson, Stella M
Published in Advances in therapy (01.11.2007)
Published in Advances in therapy (01.11.2007)
Get full text
Journal Article
A randomized, double-masked, placebo-controlled parallel study of loteprednol etabonate 0.2% in patients with seasonal allergic conjunctivitis
Shulman, David G, Lothringer, Larry L, Rubin, Jay M, Briggs, Richard B, Howes, John, Novack, Gary D, Hart, Kathryn
Published in Ophthalmology (Rochester, Minn.) (01.02.1999)
Published in Ophthalmology (Rochester, Minn.) (01.02.1999)
Get full text
Journal Article
A randomized, double-masked, placebo-controlled parallel study of loteprednol etabonate 0.2% in patients with seasonal allergic conjunctivitis11None of the investigators had a proprietary interest in loteprednol etabonate
Shulman, David G, Lothringer, Larry L, Rubin, Jay M, Briggs, Richard B, Howes, John, Novack, Gary D, Hart, Kathryn
Published in Ophthalmology (Rochester, Minn.) (01.02.1999)
Published in Ophthalmology (Rochester, Minn.) (01.02.1999)
Get full text
Journal Article